Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
DAFTAR PUSTAKA Asadullah K., Sterry W., Volk H. D. 2003. Interleukin-10 therapy – review of a new approach. Pharmacol Rev. 55:241-69. Balkwill F., Mantovani A. 2001. Inflammation and cancer: back to Virchow?. Lancet.357: 539-45. Barrat F. J., et al. 2002. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195, 603– 616. Blomhoff R., & Blomhoff H. K. 2006. Overview of retinoid metabolism and function. J. Neurobiol. 66, 606–630. Bourreille A,. Segain J. P., Raingeard de la Bletiere D., Siavoshian S., Valette G.,Galmiche J. P., and Blottiere H. M. 1999. Lack of IL-10 regulation of antigen presentation-associated molecules expressed on colonic epithelial cells. Eur J Clin Investig. 29: 48–55. Boonstra A., et al. 2006. Macrophages and myeloid DC, but not plasmacytoid DC, produce IL-10 in response to MyD88- and TRIF- dependent TLR signals, and TLR-independent signals. J. Immunol. 177,7551–7558. Carson W.E., Lindemann M. J., Baiocchi R., Linett M., Tan J. C., Chou C. C., Narula S., and Caligiuri M. A. 1995. The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood. 85: 3577–85. Colotta F., Allavena P., Sica A., Garlanda C., Mantovani A. 2009. Cancer-related inflammation, the seventh hallmark of cancer: links to genetci instability. Carcinogenesis 30: 1073-1081. Dawson H. D. et al. 2006. Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes. BMC Immunol. 7, 27. Dillon S., et al. 2004. A Toll‑like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular 42 signal‑regulated kinase 43 mitogen‑activated protein kinase and c‑Fos in dendritic cells. J. Immunol. 172, 4733–4743. Drake R.L., Vogi W., Mitchell A.W.M. 2007. Grays Anatomy. 2nd ed. China: Elsevier Churchill Livingstone p. 279. Eaden J. A., Abrams K. R., Mayberry J. F. 2001. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48: 526-535. Franke A., et al. 2008. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nature Genet. 40, 1319–1323. Fiorentino D. F., Zlotnik A., Mosmann T. R., Howard M., and O'Garra A. 1991. IL-10 inhibits cytokine production by activated macrophages. J Immunol.147: 3815-22. Gartner L.P., Hiatt J.L. 2007. Color Textbook of Histology. 3th ed. Philadelphia : W.B Saunders Company. 398-409. Gillen C.D., et al. 1994. Ulcerative colitis and Crohn’s disease: a comparison of the colorectal cancer risk in extensive colitis. Gut, 35, 1590-1592. Gommeaux J., Cano C., Garcia S., Gironella M., Pieri S., Culcasi M. et al. 2007. Colitis and colitis-assosiated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1. Mol. Cell. Biol. 27(6): 2215-28. Hana Ratnawati, Khie Khiong, Sylvia Soeng, Sri Utami Sugeng, Evan Kristiono, Shella Hudaya. 2008. Pengaruh ekstrak Buah Merah (Pandanus conoideus Lam.) terhadap berat limpa, jumlah dan proliferasi limfosit pada mencit jantan galur Swiss-webster yang diinokulasi Listeria monocytogenes. Disampaikan dalam KONAS XII dan PIN PAAI (Perhimpunan Ahli Anatomi Indonesia) Jakarta, 20-21 Juni. Hanahan D., Weinberg R.A. 2000. The Hallmarks of cancer. Cell. 100: 57-70. Hawrylowicz C. M., O’Garra, A. 2005. Potential role of interleukin‑10‑secreting regulatory T cells in allergy and asthma. Nature Rev. Immunol. 5, 271–283. I Made Budi. 2005. Seri Agrisehat Buah Merah. Jakarta: Penebar Swadaya. 17-23. Iwasaki A., Kelsall B. L. 2001. Unique functions of CD11b+, CD8α+, and double-negative Peyer’s patch dendritic cells. J. Immunol. 166, 4884–4890. Iwasaki A. 2007. Mucosal dendritic cells. Annu. Rev.Immunol. 25: 381–418 . 44 Iwasaki A., Kelsall B. L. 2001. Unique functions of CD11b+, CD8α+, and double-negative Peyer’s patch dendritic cells. J. Immunol. 166: 4884–90. Izcue A., Coombes J. L., Powrie F. 2009. Regulatory lymphocytes and intestinal inflammation. Annu. Rev. Immunol. 27, 313–338. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thu M.J. 2007 Cancer statistics, CA cancer J Clin. 57:43-66 Kang S. S., Allen P. M. 2005. Priming in the presence of IL-10 results in direct enhancement of CD8+ T cell primary responses and inhibition of secondary responses J. Immunol. 174: 5382-9. Karin M., 2008. The NF-κB kinase-a bridge between inflammation and cancer. Cell research. 18:334-342. Karin M., Greten F.R. 2005. NF-κB linking inflammation and immunity to cancer development and progression. Nature Rev Immunol. 5: 749-759. Kaiser F. et al. 2009. TPL‑2 negatively regulates interferon‑β production in macrophages and myeloid dendritic cells. J. Exp. Med. 206, 1863–1871. Kemas Ali Hanafiah. 2005. Rancangan Percobaan Apilkatif: aplikasi kondisional bidang pertanaman, perternakan, perikatan, industri, dan hayati. Jakarta: PT Raja Grafindo Persada. p10-12. Kim S. et al. 2009. Carcinoma-produced factors activate myeloid cells trough TLR2 to stimulate metatasis. Nature 457, 102-106. Kobayashi M., et al. 2003. Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J. Clin. Invest. 111: 1297–308. Kucharzik T., Lugering N., Pauels H. G., Domschke W., and Stoll R. 1995. IL-4, IL-10 and IL-13 down-regulate monocyte-chemoat-tracting protein-1 (MCP-1) production in activated intestinal epithelial cells. Clin. Exp. Immunol. 111: 152-157. Kuhn R,, Lohler J,, Rennick D,, Rajewsky K,, and Muller W. 1993. Interleukin10-deficient mice develop chronic enterocolitis. Cell. 75: 263-74. Kundu J. K., Surh Y. J. 2008. Inflammation: gearing the journey to cancer. Mutat Res 659: 15-30. 45 Lewin K. J., Riddell R. H., and Weinstein W. M. 1992. Inflammatory bowel diseases. In: Gastrointestinal Pathology and Its Clinical Implications, KJ Lewin, RH Riddell, and WM Weinstein (eds).Igaku-Shoin, New York, pp. 812-989. Lin W. W., Karin M. 2007. A cytokine-mediated link between innate immunity, inflammation and cancer. JCI. 117(5):1175-83. Mathurin P., Xiong S., Kharbanda K. K., Veal N., Miyahara T., Motomura K., Ripper R. A., Bachem M. G., and Tsukamoto H. 2002. IL-10 receptor and coreceptor expression in quiescent and activated stellate cells. Am J Physiol Gastrointest Liver Physiol. 282: 981-90. Mantovani A.2009. Cancer-related inflammation: the seventh hallmark of cancer. American Society of Clinical Oncology. 723-726. Maynard C. L. et al. 2007. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3– precursor cells in the absence of interleukin 10. Nature Immunol. 8, 931–941. Maynard C. L., Weaver C. T. 2008. Diversity in the contribution of interleukin‑10 to T‑cell‑mediated immune regulation. Immunol. Rev. 226, 219–233 . Medzhitov R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449, 819–826. Medzhitov R. 2008. Origin and physiological roles of inflammation. Nature, 454, 428-435. Moore K. W., de Waal Malefyt R., Coffman R. L., O’Garra A. 2001. Interleukin10 and the interleukin-10 receptor Annu. Rev. Immunol. 19: 683-765. Mora J. R., et al. 2006. Generation of gut-homing IgAsecreting B cells by intestinal dendritic cells. Science 314, 1157–1160. Murray P. J. 2006. Understanding and exploiting the endogenous interleukin‑10/STAT3‑mediated antiinflammatory response. Curr. Opin. Pharmacol. 6, 379–386. Mucida D., et al. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256–260. 46 O’Garra A., Barrat F. J., Castro A. G., Vicari A., Hawrylowicz C. 2008. Strategies for use of IL‑10 or its antagonists in human disease. Immunol. Rev. 223,114–131 . O’Garra A. & Vieira P. 2004. Regulatory T cells and mechanisms of immune system control. Nature Med. 10, 801–805. Riddell R. H. 1995. Pathology of idiopathic inflammatory bowel disease. In: Inflammatory Bowel Disease, JB Kirsner and RG Shorter (eds). Williams & Wilkins, Baltimore, Maryland, pp. 517-552. Roncarolo M. G. et al. 2006. Interleukin‑10‑secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28–50. Rosenberg D., Giardina C., Tanaka T. 2009. Mouse models for study of colon carcinogenesis. Carcinogenesis. 30(2): 183-96. Saraiva M., et al. 2009. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 31, 209–219. Saraiva M. & O’Garra A. 2010. The Regulation of IL-10 production by immune cells. Nature Med. 10, 170-181. Smith P. D., Ochsenbauer-Jambor, C. & Smythies, L. E. 2005. Intestinal macrophages: unique effector cells of the innate immune system. Immunol. Rev. 206: 149–59. Smythies L. E., et al. 2005. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 115: 66–75. Sun C. M., et al. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204: 1775–85. Suzuki R., Kohno H., Suige S., Nakagama H., Tanaka T. 2006. Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogenesis. 27(1):162-9 Stephensen C. B. 2001. Vitamin A, infection, and immune function. Annu. Rev. Nutr. 21: 167–192. 47 Tanaka T., et al. 2003. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 94:965–73. Tanaka T., Oyama T., Yasui Y. 2008. Dietary supplements and colorectal cancer. Curr Nuetraceut Res. 6:165-88. Tanaka T. 2009. Colorectal Carcinogenesis : Review Of Human And Experimental Animal Studies. Journal of Carcinogenesis; 8 : 5. Vakkila J., Lotze M.T. 2004. Inflammation and necrosis promote tumour growth. Nature Rev Immunol. 4: 641-648. de Waal Malefyt R., Haanen J., Spits H., Roncarolo M. G., te Velde A., Figdor C., et al. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigenspecific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med.174: 915-24. Wang, Jingsong., Fathman J. W., Vilarino G. L., Scimnone L., Andrian U. H. 2006. Transcription Factor T-Bet Regulates Inflamatory Arthritis Through Its Function In Dendritic Cell. J.Clin invest 116:414-421. Yang H., Rotter J. I. 1995. Genetic aspects of idiopathic inflammatory bowel disease. In: Inflammatory Bowel Disease, JB Kirsner and RG Shorter (eds). Williams & Wilkins, Baltimore, Maryland, pp. 301-331. Yoshimura A. 2006. Signal transduction of inflammatory cytokines and tumor development. Cancer Sci. 97(6): 439-47. Zhu J., et al. 2004. Conditional deletion of Gata3 shows its essential function in TH1–TH2 responses. Nature Immunol. 5, 1157–1165.